Aduro Biotech (ADRO) Reports Q2 Loss of $0.50

Aduro Biotech (NASDAQ: ADRO) reported Q2 EPS of ($0.50), versus ($12.27) reported last year. Revenue for the quarter came in at $9.9 million, versus $1 million reported last year.

For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance